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Galanin	N-Terminal	fragment	(1-15)	enhances	the	antidepressant	effects	
of	the	5-HT1A	receptor	agonist	8-OH-DPAT	in	the	Forced	Swimming	Test.	
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Galanin	 and	 Galanin	 (1-15)	 [GAL(1-15)]	 are	 implicated	 in	 anxiety-	 and	 depression	
related	behaviors.	Moreover,	Galanin	modulates	5-HT1A	receptor	(5-HT1AR)	function	
at	autorreceptor	and	postsynaptic	 level	 in	 the	brain.	 In	 this	 study,	we	have	analysed	
the	 ability	 of	 GAL(1-15)	 to	 modulate	 the	 effects	 of	 the	 8-OH-DPAT	 agonist	 in	 the	
Forced	Swimming	Test	(FST).	
Groups	of	rats	were	assessed	in	the	FST.	In	the	first	set	of	experiments,	to	evaluate	the	
interactions	 of	 8-OH-DPAT	 and	 GAL(1-15),	 rats	 received	 subcutaneously	 (s.c)	 the	
effective	 doses	 of	 8-OH-DPAT	 (0.25mg/Kg)	 60min	 before	 the	 test	 and	
intracerebroventricularly	 (icv)	 GAL(1-15)1nmol	 15min	 before	 the	 tests	 alone	 or	 in	
combination.	In	the	second	set	of	experiments,	groups	of	rats	received	s.c.	8-OH-DPAT	
(0.125mg/Kg),	 icv	GAL(1-15)	1nmol	and	icv	the	GALR2	antagonist	M871	3	nmol	alone	
or	in	combination.	The	locomotor	activity	was	analysed	in	the	open	field	test.	
GAL(1-15)	1nmol	enhanced	 the	antidepressant-like	effects	mediated	by	 the	effective	
dose	of	the	8-OH-DPAT.	GAL(1-15)	significantly	decreased	the	immobility	(p<0.05)	and	
climbing	 (p<0.05)	 and	 increased	 the	 swimming	 (p<0.01)	 behaviour	 induced	 by	 an	
effective	dose	of	8-OH-DPAT	(0.25mg/Kg)	in	FST.	Moreover,	after	coadministration	of	
GAL(1-15)	 and	 threshold	 dose	 of	 8-OH-DPAT	 (0.125mg/Kg)	 a	 significant	 decreased	
appeared	 in	 immobility	 (p<0.01)	 and	 climbing	 (p<0.01)	 and	 increased	 the	 swimming	
behavior	 (p<0.001)	 vs	 8-OH-DPAT	 group.	 Moreover,	 M871	 blocked	 completely	 this	
interaction.	
These	results	indicate	that	GAL(1-15)	enhances	the	antidepressant	effects	induced	by	
8-OH-DPAT	in	the	FST.	These	findings	may	give	the	basis	for	the	development	of	novel	
therapeutic	drugs.	
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